Therefore, this study evaluates the patterns of use of G-CSF at the start of the first chemotherapy cycle and the adherence to clinical practice guidelines in women with a breast cancer diagnosis reported for the period 2009-2015 in Puerto Rico. The gene discussed is CSF3; the disease is breast carcinoma.